465P Larotracking: Real-life study of locally advanced/metastatic solid tumor treated with larotrectinib in French expanded access program

Armelle Dufresne; Olivier Huillard; Cécile Dalban; Margaux Geier; J. Wassermann; Sylvie Zanetta; M. Cabourg; Bogdan Catargi; C. El Kouri; I. Hrab; M. Laramas; A. Moreira; Esma Saâda; C. Tournigand; Thibaud Valentin; Élodie Vauléon; Romaine Mayet; David Pérol; Jean Yves Blay

doi:10.1016/j.annonc.2022.07.594

Related publications

Article2020

STRUCTURED PSYCHOSOCIAL INTERVENTION FOR FRENCH PATIENTS WITH METASTATIC CANCER IS POSSIBLE IN REAL LIFE

Jean‐Loup Mouysset, David Spiegel, Barbara L. Andersen, Emmanuel Kinne, Pierre Caillat, Laetiia Dewolf, Charles Saunders, N. Rosati, T. Bouillet, Antoine Demonceaux, Philippe Orts, Jean Yves Blay

Article2020

Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program

John Walker, Célèste Lebbé, Giovanni Grignani, Paul Nathan, Luc Dirix, Eyal Fenig, Paolo A. Ascierto, Shahneen Sandhu, Rodrigo Ramella Munhoz, Elena Benincasa, Sarah Flaskett, Josh Reed, Arne Engelsberg, Hariharan Subramanian, Vijay Kasturi

Article2023

Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades

Maud Toulmonde, Derek Dinart, Mehdi Brahmi, Benjamin Verret, Myriam Jean‐Denis, Françoise Ducimetière, G. Désolneux, Pierre Méeus, Jean Palussière, Xavier Buy, Amine Bouhamama, P. Gillon, Armelle Dufresne, Clémence Hénon, François Le Loarer, Marie Karanian, Carine Ngo, Simone Mathoulin‐Pélissier, Carine Bellera, Axel Le Cesne, Jean Yves Blay, Antoîne Italiano

Corrigendum2025

Corrigendum to “Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)”

Emmanuelle Bompas, A. Le Cesne, Emmanuelle Tresch‐Bruneel, Loïc Lebellec, Valérie Laurence, Olivier Collard, Esma Saâda-Bouzid, Nicolás Isambert, Jean Yves Blay, Éric Amela, Sébastien Salas, Christine Chevreau, François Bertucci, Antoine Italiano, Stéphanie Clisant, Nicolas Penel

Article2018

Second-line avelumab treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from a global expanded access program (EAP).

John Walker, Vijay Kasturi, Célèste Lebbé, Shahneen Sandhu, Giovanni Grignani, Meliessa Hennessy, Steven Hildemann, Josh Reed, Hariharan Subramanian